International Journal of Clinical Oncology· 2026Q1
Ziyaret öncesi kan alma işlemi bazı kanser hastaları için bekleme süresini azaltıyor
A prospective study evaluating the impact of waiting time on blood testing and clinical workflows in cancer patients
- 0atıf
- Q1SCImago
- 2026yıl
Kısa özet
Ziyaret öncesi kan alma işlemi, kanser hastaları için kontrol girişinden kemoterapiye kadar olan bekleme süresini ortalama 30 dakika (3,3'e karşı 3,9 saat, p=0,025) azalttı; hastaların %24'ü yükte azalma bildirdi ve dolaylı maliyetler hasta başına yaklaşık 1198 Japon Yeni düştü.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Ziyaret öncesi kan alma işlemi, kanser hastalarında kemoterapiye kadar olan bekleme süresini ortalama 30 dakika (3,3'e karşı 3,9 saat, p=0,025) azalttı.
- Hastaların %24'ü ziyaret öncesi kan alma işlemi ile yükte azalma bildirdi.
- Dolaylı maliyetler hasta başına yaklaşık 1198 Japon Yeni azaldı.
- Faydalar, hem kan alma hem de kemoterapi tesislerine 30 dakika mesafede yaşayan hastalar için daha fazlaydı.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Abstract Background Long waiting times on chemotherapy days increase patient burden. Pre-visit blood sampling may streamline workflows; however, its real-world impact remains unclear. Methods This prospective study collected data on waiting times for pre-visit vs same-day blood sampling in 50 cancer patients receiving chemotherapy between October 2024 and February 2025 at St. Marianna University Hospital. Pre‑visit and same‑day blood sampling was compared in the same patients across four waiting times: (i) check-in to consultation, (ii) check-in to check-out, and (iii–iv) extended measures incorporating travel time. For times (iii) and (iv), travel time during pre-visit was also included. Patient and physician satisfaction and indirect costs were also evaluated. Results The median waiting time from check-in to consultation was 1.8 and 2.2 h for pre-visit and same-day sampling, respectively; when chemotherapy and check-out were included (ii), total duration was similar (6.3 vs 6.3 h). Extended measures (iii–iv) tended to be longer with pre-visit sampling. After excluding the two outliers, waiting time from check-in to chemotherapy was significantly shorter for pre-visit vs same-day sampling (3.3 vs 3.9 h, p =0.025). Patient satisfaction was favorable, and 24.0% of patients reported reduced burden. Indirect costs improved by approximately 1198 Japanese yen per patient, with benefits reported in approximately half of the cases. Subgroup analyses suggested greater benefits for patients living within 30 min of both pre-visit blood sampling and chemotherapy facilities. Conclusions Pre-visit blood sampling may reduce waiting time and perceived burden for selected patients, although overall time savings were modest. Trial registration University Hospital Medical Information Network (UMIN) Clinical Trials Registry: UMIN000055757.
Yazarların özeti; kaynağından alınmıştır. International Journal of Clinical Oncology, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Acil Sağlık Hizmetleri
Emergency Medical ServicesHealth Professions